Iplaceh

Bitter Candytuft Fresh Plant Extract, the active ingredient in Iplaceh, is a herbal botanical presented as a standardized extract/oral liquid for oral use. It is traditionally used to support digestive comfort and mild gastrointestinal discomfort in adults.

GNH USA supplies Iplaceh as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Iplaceh is a botanical preparation that acts on the gastrointestinal tract to promote normal digestive function.

Indigestion: helps alleviate mild dyspepsia symptoms. Functional stomach upset: promotes soothing of occasional gastrointestinal discomfort. Mild nausea: may reduce occasional nausea episodes.

Iplaceh is generally well tolerated, but some users may experience adverse reactions.

Common Side Effects: - Mild abdominal bloating. - Transient heartburn. - Slightly bitter after‑taste. - Mild headache. - Temporary dry mouth.

Serious or Rare Side Effects: - Allergic skin rash or urticaria. - Angioedema involving face or throat. - Severe gastrointestinal upset with vomiting. - Anaphylactic reaction requiring emergency care.

Before using Iplaceh, consider the following safety measures. - Pregnancy: consult a healthcare professional before use. - Breastfeeding: use with caution and under medical advice. - Known allergy: avoid if hypersensitive to any listed plant extracts. - Concomitant medications: discuss potential interactions with a physician. - Severe liver disease: use only if medically indicated. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Iplaceh may interact with certain medicines; awareness of the level of interaction helps manage risk.

Major Interactions (Avoid): - Anticoagulants: may increase bleeding tendency. - Central nervous system depressants: may enhance sedative effects.

Moderate Interactions (Monitor Closely): - Antihistamines: possible alteration of metabolism. - Antidiabetic agents: may affect blood glucose control. - Other herbal products: risk of additive gastrointestinal effects.